Key result
Precision phenotyping identifies three DCM subtypes that improve prognostic risk assessment over traditional models.
Why the study?
Does precision phenotyping using clinical and biological data improve prognostic value compared to traditional risk models in patients with dilated cardiomyopathy?
Does precision phenotyping using clinical and biological data improve prognostic value compared to traditional risk models in patients with dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
Identification of three distinct DCM subtypes using clinical and biological data adds prognostic value to traditional risk models and may enable precision medicine.
Three reproducible, mechanistically distinct DCM subtypes were identified using widely available clinical and biological data, adding prognostic value to traditional risk models. They may improve patient selection for novel interventions, thereby enabling precision medicine.
No takes yet. Share an insight, caveat, or question.
Tayal et al. (2022) studied this question. Precision phenotyping using clinical and biological data identified three distinct dilated cardiomyopathy subtypes that added prognostic value to traditional risk models.
Synapse has enriched 10 related papers. Consider them for comparative context: